Loading clinical trials...

Novel Determinants and Measures of Smokeless Tobacco Use: Study 2 | Clinical Trials | Clareo Health

COMPLETEDNANCT01067599

Novel Determinants and Measures of Smokeless Tobacco Use: Study 2

The research project will determine the level of nicotine in ST products that will lead to the greatest reduction in toxicant exposure

Lead sponsor: University of Minnesota•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

Accelerated dTMS Smoking Cessation

NCT07292883 · Tobacco Use Disorder, Addiction Nicotine

RECRUITINGPhase 2

Cannabidiol for Reducing Cigarette Use

NCT06218056 · Tobacco Use Disorder, Tobacco Smoking, and more

RECRUITINGNA

Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients

NCT07466875 · Nicotine Dependence, Nicotine Withdrawal, and more

RECRUITINGPhase 4

Smoking Cessation and Menstrual Cycle Phase

NCT05515354 · Nicotine Dependence, Tobacco Smoking, and more

RECRUITINGNA

Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

NCT01036581 · Drug Abuse, Nicotine Dependence

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 26, 2018Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment278

Start dateMar 2012

Last updatedFeb 26, 2018

Condition

Tobacco Use Disorder Nicotine Dependence

Locations shown

University of Minnesota

Minneapolis, Minnesota

Oregon Research Institute

Eugene, Oregon

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 26, 2018Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions